Re: Five-factor Prognostic Model for Survival of Post-platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors. Alfred Witjes J. Eur Urol 2021;80:113.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Alfred Witjes J. Re: Five-factor Prognostic Model for Survival of Post-platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors. Eur Urol 2021;80:113.
PMID: 33593656